Company: SNSE
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0000950170-25-053033
Chunk: 52

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 52
---
 (1)          |     |                          |  5,000 |

(1) The Board dissolved the Science and Technology Committee on December 10, 2024, effective as of December 31, 2024. These retainers will not be paid beginning in 2025. Under the 2024 Amended Policy, each non-employee director receives equity compensation as follows: Initial equity award . Each new non-employee director elected or appointed to our board of directors will be granted an option to purchase 38,000 shares of our common stock, vesting in 36 substantially equal monthly installments following the grant date. In addition, if an independent chair is elected or appointed to the Board, the independent chair will be granted an additional option to purchase 10,000 shares of our common stock, vesting in full on the first anniversary of the date of grant. Annual equity awards . On the date of each annual meeting of stockholders of our company, each non-employee director who has served as a non-employee director for at least six months prior to such stockholder meeting and who will continue to serve on our board of directors will be granted an option to purchase 19,000 shares of our common stock, vesting in monthly installments such that the option is fully vested on the earlier of the first anniversary of the grant date or the date of our next annual stockholder meeting.

<div align='center'>34</div>

All equity awards held by a non-employee director will vest in full upon a change in control.

In addition, under the 2024 Amended Policy all stock options granted to non-employee directors shall remain exercisable following the termination of a director's service to the Company until the earliest of (x) four years following such termination of service, (y) the expiration of the option and (z) the later of (i) the number of full years of service to the Company provided by such director and (ii) three months after termination for any reason other than death or disability, 12 months after termination due to disability or 18 months due to death. Stock options shall expire immediately upon termination of a director for cause. The foregoing provisions regarding the post-termination exercise period apply to all stock options previously granted to our directors and all stock options granted in the future.

<div align='center'>35</div>

EQUITY COMPENSATION PLAN INFORMATION The following table shows information regarding our equity compensation plans in effect as of December 31, 2024.

| Plan